Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wang, 2020, A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence, Int J Antimicrob Agents, 105948, 10.1016/j.ijantimicag.2020.105948
Tuite, 2020, Estimation of COVID-19 outbreak size in Italy, Lancet Infect Dis, 10.1016/S1473-3099(20)30227-9
Onder, 2020, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy, JAMA, 10.1001/jama.2020.4683
Sepriano, 2020, Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis, Ann Rheum Dis, 10.1136/annrheumdis-2019-216653
Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet (London, England), 6736, 19
Smolen, 2020, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update, Ann Rheum Dis, 10.1136/annrheumdis-2019-216655
Benucci, 2020, Old and new antirheumatic drugs for the treatment of COVID-19, Joint Bone Spine, 87, 195, 10.1016/j.jbspin.2020.03.013
Quartuccio, 2020, Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome, Joint Bone Spine, 87, 191, 10.1016/j.jbspin.2020.03.011
Haberman, 2020, Covid-19 in immune-mediated inflammatory diseases - case series from New York, N Engl J Med, 10.1056/NEJMc2009567
Monti, 2020, Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies, Ann Rheum Dis, 10.1136/annrheumdis-2020-217424
Favalli, 2020, Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis, J Rheumatol, 10.3899/jrheum.200507
Richez, 2020, Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases, Joint Bone Spine, 87, 187, 10.1016/j.jbspin.2020.03.010
World Health Organization, 2020
D’Antiga, 2020, Coronaviruses immunosuppressed patients. The facts during the third epidemic, Liver Transpl, 10.1002/lt.25756
Shi, 2020, COVID-19 infection: the perspectives on immune responses, Cell Death Differ, 382
Hui, 2018, Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission, Lancet Infect Dis, 18, e217, 10.1016/S1473-3099(18)30127-0
Favalli, 2020, COVID-19 infection and rheumatoid arthritis: faraway, so close!, Autoimmun Rev, 10.1016/j.autrev.2020.102523
Quartuccio, 2018, Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: usefulness of administrative data, J Adv Res, 15, 87, 10.1016/j.jare.2018.09.003
Borba, 2020, Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial, JAMA Netw Open, 3, e208857, 10.1001/jamanetworkopen.2020.8857